Hetero Labs Ltd V Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HETERO LABS LTD V, and what generic and branded alternatives to HETERO LABS LTD V drugs are available?
HETERO LABS LTD V has seventy-two approved drugs.
There are four tentative approvals on HETERO LABS LTD V drugs.
Drugs and US Patents for Hetero Labs Ltd V
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hetero Labs Ltd V | APIXABAN | apixaban | TABLET;ORAL | 210066-001 | Nov 21, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Hetero Labs Ltd V | SILODOSIN | silodosin | CAPSULE;ORAL | 204793-002 | Feb 14, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Hetero Labs Ltd V | SILODOSIN | silodosin | CAPSULE;ORAL | 204793-001 | Feb 14, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Hetero Labs Ltd V | VALSARTAN | valsartan | TABLET;ORAL | 203311-001 | Jan 5, 2015 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.